Ampharm Limited

POWER SEARCH PRICING

SOLUTIONS

ampharm limited Company Information

Live

MatureMidHigh

Company Number

00992452

Website

http://mcdonalds.co.uk

Registered Address

63-65 whitehorse road, croydon, CR0 2JG

Industry

Dispensing chemist in specialised stores

Telephone

02086534978

Next Accounts Due

December 2024

Group Structure

View All

Directors

Sanjaykumar Patel31 Years

Shareholders

sanjaykumar jayantilal patel 100%

ampharm limited Estimated Valuation

£3.9m

Pomanda estimates the enterprise value of AMPHARM LIMITED at £3.9m based on Net Assets of £1.7m and 2.27x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Ampharm Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Ampharm Limited is a live company located in croydon, CR0 2JG with a Companies House number of 00992452. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in October 1970, it's largest shareholder is sanjaykumar jayantilal patel with a 100% stake. Ampharm Limited is a mature, mid sized company, Pomanda has estimated its turnover at £5.3m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Ampharm Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating4.5out of 5

4 Strong

3 Regular

5 Weak

Size

annual sales of £5.3m, make it smaller than the average company (£12.1m)

Growth

3 year (CAGR) sales growth of 25%, show it is growing at a faster rate (5.4%)

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for ampharm limited. Get real-time insights into ampharm limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for ampharm limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

AMPHARM LIMITED group structure

Ampharm Limited has no subsidiary companies.

Ultimate parent company

AMPHARM LIMITED

00992452

AMPHARM LIMITED Shareholders

sanjaykumar jayantilal patel

100%

Ampharm Limited currently has 1 director, Sanjaykumar Patel serving since Sep 1992.

officer	country	age	start	end	role
Sanjaykumar Patel		61 years	Sep 1992	-	Director

EXPORT

Ampharm Limited's latest turnover from March 2023 is estimated at £5.3 million and the company has net assets of £1.7 million. According to their latest financial statements, Ampharm Limited has 7 employees and maintains cash reserves of £92.4 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	5,348,109	5,253,236	3,573,043	2,709,969	2,488,009	2,720,272	1,755,563	1,601,263	2,746,077	2,538,741	2,209,068	1,987,370	1,773,762	2,268,102
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	3,641,668	3,563,859	2,482,270	1,918,993	1,761,579	1,889,336	1,205,554	1,108,114	1,917,744	1,758,586	1,537,773	1,407,195	1,247,763	1,579,160
Gross Profit	1,706,441	1,689,377	1,090,773	790,976	726,430	830,936	550,009	493,148	828,333	780,155	671,295	580,175	525,998	688,942
Admin Expenses	1,371,792	1,377,075	817,269	618,989	628,686	710,105	435,312	314,991	708,636	651,920	535,489	422,800	401,887	358,860
Operating Profit	334,649	312,302	273,504	171,987	97,744	120,831	114,697	178,157	119,697	128,235	135,806	157,375	124,111	330,082
Interest Payable	140,147	99,566	96,740	103,070	120,145	74,405	27,739	13,728	0	0	0	0	0	0
Interest Receivable	4,267	626	54	37	182	97	58	125	100	71	43	54	37	5
Pre-Tax Profit	198,769	213,363	176,817	68,954	-22,219	46,522	87,016	164,554	119,796	128,306	135,849	157,430	124,147	330,088
Tax	-37,766	-40,539	-33,595	-13,101	0	-8,839	-17,403	-32,911	-25,157	-29,510	-32,604	-40,932	-34,761	-92,424
Profit After Tax	161,003	172,824	143,222	55,853	-22,219	37,683	69,613	131,643	94,639	98,796	103,245	116,498	89,386	237,663
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	161,003	172,824	143,222	55,853	-22,219	37,683	69,613	131,643	94,639	98,796	103,245	116,498	89,386	237,663
Employee Costs	153,697	123,337	116,266	113,567	110,978	109,507	106,235	104,359	414,323	379,029	304,184	252,378	236,853	285,047
Number Of Employees	7	6	6	6	6	6	6	6	24	22	18	15	14	17
EBITDA*	368,620	346,727	308,533	207,823	134,655	159,174	154,735	220,670	165,511	178,451	157,276	171,972	137,038	343,391

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	235,957	269,928	304,353	339,382	375,218	412,129	449,823	489,861	532,374	578,188	494,423	215,895	222,261	234,780
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	2,326,213	2,326,213	2,326,213	2,172,379	2,172,379	2,172,379	700,000	700,000	700,000	700,000	700,000	700,000	700,000	700,000
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	2,562,170	2,596,141	2,630,566	2,511,761	2,547,597	2,584,508	1,149,823	1,189,861	1,232,374	1,278,188	1,194,423	915,895	922,261	934,780
Stock & work in progress	91,128	88,395	90,497	83,515	92,758	105,979	96,068	89,833	93,798	95,750	68,175	76,688	74,969	75,503
Trade Debtors	1,268,374	1,249,887	1,030,471	810,672	680,802	771,963	498,534	393,432	444,586	421,166	419,221	351,312	244,651	347,837
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	186,603	172,225	159,471	147,449	148,837	0	162,554	144,189	0	0	0	0	0	0
Cash	92,425	108,385	58,625	48,727	25,465	22,965	15,784	30,903	19,135	20,689	7,872	9,304	12,446	2,158
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	1,638,530	1,618,892	1,339,064	1,090,363	947,862	900,907	772,940	658,357	557,519	537,605	495,268	437,304	332,066	425,498
total assets	4,200,700	4,215,033	3,969,630	3,602,124	3,495,459	3,485,415	1,922,763	1,848,218	1,789,893	1,815,793	1,689,691	1,353,199	1,254,327	1,360,278
Bank overdraft	139,200	139,200	139,200	139,200	146,032	139,200	124,469	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	52,675	0	0	0	0	0	0
Trade Creditors	221,120	249,841	217,768	245,737	206,322	237,961	185,271	203,544	411,561	490,540	508,467	589,301	571,892	663,877
Group/Directors Accounts	641,420	606,960	534,960	276,911	180,045	71,816	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	294,317	366,109	291,376	181,674	175,104	130,967	89,430	109,050	0	0	0	0	0	0
total current liabilities	1,296,057	1,362,110	1,183,304	843,522	707,503	579,944	399,170	365,269	411,561	490,540	508,467	589,301	571,892	663,877
loans	1,173,448	1,282,731	1,388,958	1,504,456	1,589,663	1,684,959	340,764	369,733	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	396,759	438,319	393,086	79,005	114,040	217,392
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	1,173,448	1,282,731	1,388,958	1,504,456	1,589,663	1,684,959	340,764	369,733	396,759	438,319	393,086	79,005	114,040	217,392
total liabilities	2,469,505	2,644,841	2,572,262	2,347,978	2,297,166	2,264,903	739,934	735,002	808,320	928,859	901,553	668,306	685,932	881,269
net assets	1,731,195	1,570,192	1,397,368	1,254,146	1,198,293	1,220,512	1,182,829	1,113,216	981,573	886,934	788,138	684,893	568,395	479,009
total shareholders funds	1,731,195	1,570,192	1,397,368	1,254,146	1,198,293	1,220,512	1,182,829	1,113,216	981,573	886,934	788,138	684,893	568,395	479,009

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	334,649	312,302	273,504	171,987	97,744	120,831	114,697	178,157	119,697	128,235	135,806	157,375	124,111	330,082
Depreciation	33,971	34,425	35,029	35,836	36,911	38,343	40,038	42,513	45,814	50,216	21,470	14,597	12,927	13,309
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	-37,766	-40,539	-33,595	-13,101	0	-8,839	-17,403	-32,911	-25,157	-29,510	-32,604	-40,932	-34,761	-92,424
Stock	2,733	-2,102	6,982	-9,243	-13,221	9,911	6,235	-3,965	-1,952	27,575	-8,513	1,719	-534	75,503
Debtors	32,865	232,170	231,821	128,482	57,676	110,875	123,467	93,035	23,420	1,945	67,909	106,661	-103,186	347,837
Creditors	-28,721	32,073	-27,969	39,415	-31,639	52,690	-18,273	-208,017	-78,979	-17,927	-80,834	17,409	-91,985	663,877
Accruals and Deferred Income	-71,792	74,733	109,702	6,570	44,137	41,537	-19,620	109,050	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	194,743	182,926	117,868	121,468	102,698	123,776	-30,263	-278	39,907	101,494	-15,558	40,069	114,012	491,504
Investing Activities
capital expenditure	0	0	0	0	0	-649	0	0	0	-133,981	-299,998	-8,231	-408	-248,089
Change in Investments	0	0	153,834	0	0	1,472,379	0	0	0	0	0	0	0	700,000
cash flow from investments	0	0	-153,834	0	0	-1,473,028	0	0	0	-133,981	-299,998	-8,231	-408	-948,089
Financing Activities
Bank loans	0	0	0	0	0	0	-52,675	52,675	0	0	0	0	0	0
Group/Directors Accounts	34,460	72,000	258,049	96,866	108,229	71,816	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	-109,283	-106,227	-115,498	-85,207	-95,296	1,344,195	-28,969	369,733	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	-396,759	-41,560	45,233	314,081	-35,035	-103,352	217,392
share issue	0	0	0	0	0	0	0	0	0	0	0	0	0	241,346
interest	-135,880	-98,940	-96,686	-103,033	-119,963	-74,308	-27,681	-13,603	100	71	43	54	37	5
cash flow from financing	-210,703	-133,167	45,865	-91,374	-107,030	1,341,703	-109,325	12,046	-41,460	45,304	314,124	-34,981	-103,315	458,743
cash and cash equivalents
cash	-15,960	49,760	9,898	23,262	2,500	7,181	-15,119	11,768	-1,554	12,817	-1,432	-3,142	10,288	2,158
overdraft	0	0	0	-6,832	6,832	14,731	124,469	0	0	0	0	0	0	0
change in cash	-15,960	49,760	9,898	30,094	-4,332	-7,550	-139,588	11,768	-1,554	12,817	-1,432	-3,142	10,288	2,158

P&L

March 2023

turnover

5.3m

+2%

operating profit

334.6k

gross margin

32%

-0.78%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

1.7m

+0.1%

total assets

4.2m

cash

92.4k

-0.15%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

upl limited

pharma holdings limited

lordsfield limited

dilmer limited

3.5

preddy newco limited

1.5

company number

00992452

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

October 1970

age

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

address

63-65 whitehorse road, croydon, CR0 2JG

last accounts submitted

March 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 11 charges/mortgages relating to ampharm limited. Currently there are 4 open charges and 7 have been satisfied in the past.

ampharm limited Company Information

ampharm limited Estimated Valuation

ampharm limited Estimated Valuation

ampharm limited Estimated Valuation

Ampharm Limited AI Business Plan

Ampharm Limited Overview

Ampharm Limited Health Check

ampharm limited Credit Report and Business Information

Ampharm Limited Competitor Analysis

ampharm limited Ownership

ampharm limited directors

AMPHARM LIMITED financials

ampharm limited company details

ampharm limited Charges & Mortgages

ampharm limited Companies House Filings - See Documents